1. China Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Meinian Onehealth Healthcare Holdings Co Ltd Class A

Meinian Onehealth Healthcare Holdings Co Ltd Class A

SSZSE:002044
4.92
CNY
+0.17
(+3.58%)
19.69BMarket Cap
Oct 31Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.04
0.71
0.73
1.13
1.7
2.27
2.26
1.99
2.99
2.16
2.8
2.65
2.54
- -
Basic EPS, GAAP
-0.01
0.07
0.09
0.12
0.16
0.22
-0.23
0.14
0.02
-0.14
0.13
0.07
0.07
- -
Free Cash Flow per Basic Share
0.01
-0.02
-0.01
0.09
0.14
0.19
0.22
0.17
0.53
0.28
0.42
0.3
0.34
- -
Dividend per Share
0.07
- -
0.01
0.01
0.03
0.1
0.14
0.1
0.05
0.03
0.04
0.05
0.05
0.03
Book Value per Share
0.44
1.78
0.88
1.68
1.75
1.78
1.87
2.04
2.05
1.88
1.97
2.02
2.08
2.03
Tangible Book Value per Share
0.39
1.62
0.75
0.62
0.63
0.47
0.78
0.97
0.96
0.69
0.7
0.62
0.64
0.59
Basic Weighted Avg Shares
742
2,018
2,883
3,826
3,688
3,730
3,767
3,936
3,079
3,993
3,889
4,032
4,076
3,837
Sales/Revenue/Turnover
769
1,431
2,101
4,314
6,282
8,458
8,525
7,848
9,216
8,616
10,894
10,702
10,360
- -
Operating Margin (%)
11.1
11.91
15.51
15.08
14.46
16.25
12.34
5.38
8.45
0.84
11.2
10.35
10.12
- -
Depreciation Expense
16
55
77
154
215
317
400
408
1,075
1,166
1,202
1,224
1,198
- -
Net Income, GAAP
-6
140
260
452
584
821
-866
551
62
-559
506
282
285
- -
Effective Tax Rate (%)
- -
18.28
20.27
21.51
24.64
24.21
- -
18.11
56.36
- -
21.13
30.97
33.52
- -
Profit Margin (%)
-0.81
9.79
12.39
10.47
9.3
9.7
-10.16
7.02
0.67
-6.49
4.64
2.64
2.75
- -
Working Capital
175
503
785
373
167
-848
708
-798
-1,150
-2,274
-1,723
-1,899
-1,429
-1,659
LT Debt
22
4
86
245
1,000
2,250
2,551
4,195
3,007
2,380
2,479
2,446
2,066
2,010
Total Equity
427
1,494
3,242
6,192
7,012
7,390
8,154
8,672
8,778
8,102
8,410
8,703
8,932
8,726
Return on Invested Capital (%)
- -
11.93
10.05
8.61
7.42
8.68
- -
4.11
1.07
- -
5.24
3
2.74
- -
Return on Capital (%)
- -
12.21
8.86
7.76
7.22
7.62
- -
4.7
0.73
- -
4.25
2.59
2.68
- -
Return on Common Equity (%)
-1.5
15.82
11.62
10.13
9.41
12.42
-12.4
7.21
0.77
-7.26
6.71
3.62
3.56
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
4,030
3,924
4,013
LT Borrowings
132
165
105
LT Finance Leases
1,934
1,866
1,905
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3,914
3,914
3,914
Market Capitalization
20,667
22,037
19,689

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
7,401
6,254
6,085
Cash, Cash Equivalents & STI
3,632
2,648
2,087
Accounts Receivable, Net
2,934
2,753
3,024
Inventories
191
171
156
Total Current Liabilities
8,830
7,896
7,744
Payables & Accruals
- -
- -
- -
ST Debt
4,030
3,924
4,013
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.98%
0.69%
2.63%
Free Cash Flow
-196.8%
29.78%
13.57%
Net Income, GAAP
-155.6%
-266.03%
1.09%
Sales/Revenue/Turnover
21.08%
6.48%
-3.2%
Total Cash Common Dividend
55.2%
-4.35%
-6.87%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,801
2,404
2,935
3,561
10,702
2025
1,754
2,355
- -
3,434
10,360
2026
1,584
2,261
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.07
0.02
0.06
0.07
0.07
2025
-0.07
0.01
- -
0.06
0.07
2026
-0.07
0.02
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.03
0.01
0.05
2025
0.01
0.01
- -
0.01
0.05
2026
0.01
0.01
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Tao Xu
Full Time Employees
33,119
Sector
Health services
Industry
Medical/Nursing services
Address
Health Intelligence Valley Shanghai JS China 200072
IPO Date
May 18, 2005
Website
health-100.cn
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Mobile-health Network Solutions (NASDAQ:MNDR)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Meinian Onehealth Healthcare Holdings Co., Ltd. (002044.SZ) operates as China's leading provider of professional health examination and preventive healthcare services, offering comprehensive physical exams, health consultations, assessments, and interventions through an extensive network of centers. The company delivers core products including popular, high-end, and occupational health checkups such as physicals, blood tests, electrocardiograms, imaging diagnostics, genetic testing, and specialized AI-driven offerings like BrainRuijia for stroke screening, LungJingning for lung nodules, coronary artery calcium scoring, cognitive assessments, ECG analysis, breast ultrasound, fundus exams, pediatric bone age evaluation, and innovative AI traditional Chinese medicine physical exams; it also provides full-cycle health management via digital platforms including the Bian Que SAAS system, LIS laboratory management, PACS imaging systems, and the Health Little Meixue AI robot for blood sugar management and personalized digital twins. Meinian Onehealth manages prominent brands such as Mei Nian Da Health, Ci Ming Physical Examination, Ci Ming Oya, and Meizhao Health, alongside supplementary services in investment management, software development, pharmaceutical retail, financial leasing, and factoring. Founded in 2004 and headquartered in Shanghai, China, the company primarily serves individual consumers, group corporate clients, and government programs across the preventive medicine sector, employing over 38,000 staff and operating predominantly within China with a focus on digital transformation and AI integration to enhance efficiency and customer experience. In recent developments, Meinian Onehealth agreed in April 2025 to acquire a 90% stake in Feicheng Meinian OneHealth Management Co., Ltd. for CNY 26.2 million, issuing 4.8 million shares as consideration, with board and shareholder approvals secured by August 2025 to bolster its regional health management footprint; it cancelled a prior proposed acquisition of an 81% stake in Xiamen Yincheng Meinian OneHealth Management Co., Ltd., while renewing a genetic testing services framework with Mega Genomics in January 2024 and launching key AI products including the Health Little Meixue robot in August 2024 in partnership with Huawei Cloud and Shanghai Runda Medical Technology.